Literature DB >> 10567372

Sequence, purification, and cloning of an intracellular serine protease, quiescent cell proline dipeptidase.

R Underwood1, M Chiravuri, H Lee, T Schmitz, A K Kabcenell, K Yardley, B T Huber.   

Abstract

We recently observed that specific inhibitors of post-proline cleaving aminodipeptidases cause apoptosis in quiescent lymphocytes in a process independent of CD26/dipeptidyl peptidase IV. These results led to the isolation and cloning of a new protease that we have termed quiescent cell proline dipeptidase (QPP). QPP activity was purified from CD26(-) Jurkat T cells. The protein was identified by labeling with [(3)H]diisopropylfluorophosphate and subjected to tryptic digestion and partial amino acid sequencing. The peptide sequences were used to identify expressed sequence tag clones. The cDNA of QPP contains an open reading frame of 1476 base pairs, coding for a protein of 492 amino acids. The amino acid sequence of QPP reveals similarity with prolylcarboxypeptidase. The putative active site residues serine, aspartic acid, and histidine of QPP show an ordering of the catalytic triad similar to that seen in the post-proline cleaving exopeptidases prolylcarboxypeptidase and CD26/dipeptidyl peptidase IV. The post-proline cleaving activity of QPP has an unusually broad pH range in that it is able to cleave substrate molecules at acidic pH as well as at neutral pH. QPP has also been detected in nonlymphocytic cell lines, indicating that this enzyme activity may play an important role in other tissues as well.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10567372     DOI: 10.1074/jbc.274.48.34053

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Sitagliptin reduces plaque macrophage content and stabilises arteriosclerotic lesions in Apoe (-/-) mice.

Authors:  F Vittone; A Liberman; D Vasic; R Ostertag; M Esser; D Walcher; A Ludwig; N Marx; M Burgmaier
Journal:  Diabetologia       Date:  2012-05-18       Impact factor: 10.122

2.  Dipeptidyl peptidase 2 apoptosis assay determines the B-cell activation stage and predicts prognosis in chronic lymphocytic leukemia.

Authors:  Alexey V Danilov; Olga V Danilova; Jennifer R Brown; Arthur Rabinowitz; Andreas K Klein; Brigitte T Huber
Journal:  Exp Hematol       Date:  2010-09-24       Impact factor: 3.084

3.  Synthesis and activity of a potent, specific azabicyclo[3.3.0]-octane-based DPP II inhibitor.

Authors:  Olga Danilova; Bei Li; A Katrin Szardenings; Brigitte T Huber; Jonathan S Rosenblum
Journal:  Bioorg Med Chem Lett       Date:  2006-10-10       Impact factor: 2.823

4.  Cloning and functional expression of rat kidney dipeptidyl peptidase II.

Authors:  K M Fukasawa; K Fukasawa; K Higaki; N Shiina; M Ohno; S Ito; J Otogoto; N Ota
Journal:  Biochem J       Date:  2001-01-15       Impact factor: 3.857

5.  Cloning and characterization of dipeptidyl peptidase 10, a new member of an emerging subgroup of serine proteases.

Authors:  Shu Y Qi; Pierre J Riviere; Jerzy Trojnar; Jean-Louis Junien; Karen O Akinsanya
Journal:  Biochem J       Date:  2003-07-01       Impact factor: 3.857

6.  Th17 differentiation is the default program for DPP2-deficient T-cell differentiation.

Authors:  Deanna A Mele; James F Sampson; Brigitte T Huber
Journal:  Eur J Immunol       Date:  2011-05-13       Impact factor: 5.532

7.  Kinetic investigation of human dipeptidyl peptidase II (DPPII)-mediated hydrolysis of dipeptide derivatives and its identification as quiescent cell proline dipeptidase (QPP)/dipeptidyl peptidase 7 (DPP7).

Authors:  Marie-Berthe Maes; Anne-Marie Lambeir; Kambiz Gilany; Kristel Senten; Pieter Van der Veken; Barbara Leiting; Koen Augustyns; Simon Scharpé; Ingrid De Meester
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

8.  Neurogenin 3-specific dipeptidyl peptidase-2 deficiency causes impaired glucose tolerance, insulin resistance, and visceral obesity.

Authors:  Olga V Danilova; Albert K Tai; Deanna A Mele; Martin Beinborn; Andrew B Leiter; Andrew S Greenberg; James W Perfield; Jason Defuria; Praful S Singru; Ronald M Lechan; Brigitte T Huber
Journal:  Endocrinology       Date:  2009-10-09       Impact factor: 4.736

9.  Aminopeptidase activities as prospective urinary biomarkers for bladder cancer.

Authors:  Jennifer M Taylor; Mariana Yaneva; Kevin Velasco; John Philip; Hediye Erdjument-Bromage; Irina Ostrovnaya; Hans G Lilja; Bernard H Bochner; Paul Tempst
Journal:  Proteomics Clin Appl       Date:  2014-03-31       Impact factor: 3.494

10.  Catalytic properties and inhibition of proline-specific dipeptidyl peptidases II, IV and VII.

Authors:  Barbara Leiting; KellyAnn D Pryor; Joseph K Wu; Frank Marsilio; Reshma A Patel; Charles S Craik; Jonathan A Ellman; Richard T Cummings; Nancy A Thornberry
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.